March 3, 2016

Purification of Interferon α-2a—a process development study

Biosimilar production is not required to follow the same process as the originator, encouraging the choice of new and potentially more efficient manufacturing steps during process development. In this work a process for Interferon α-2a was developed, using HTPD techniques and DoE methodology.

View Presentation